KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Novavax (NVAX) Shares Outstanding: 2009-2022

Historic Shares Outstanding for Novavax (NVAX) over the last 7 years, with Dec 2022 value amounting to $86.8 million.

  • Novavax's Shares Outstanding rose 13.57% to $86.8 million in Q4 2022 from the same period last year, while for Dec 2022 it was $86.8 million, marking a year-over-year increase of 13.57%. This contributed to the annual value of $86.8 million for FY2022, which is 13.57% up from last year.
  • According to the latest figures from Q4 2022, Novavax's Shares Outstanding is $86.8 million, which was up 9.60% from $79.2 million recorded in Q3 2022.
  • In the past 5 years, Novavax's Shares Outstanding ranged from a high of $86.8 million in Q4 2022 and a low of $17.4 million during Q1 2018.
  • Moreover, its 3-year median value for Shares Outstanding was $75.3 million (2021), whereas its average is $72.9 million.
  • Data for Novavax's Shares Outstanding shows a peak YoY skyrocketed of 160.74% (in 2020) over the last 5 years.
  • Over the past 5 years, Novavax's Shares Outstanding (Quarterly) stood at $19.2 million in 2018, then spiked by 68.35% to $32.4 million in 2019, then soared by 120.22% to $71.4 million in 2020, then grew by 7.12% to $76.4 million in 2021, then climbed by 13.57% to $86.8 million in 2022.
  • Its Shares Outstanding was $86.8 million in Q4 2022, compared to $79.2 million in Q3 2022 and $78.8 million in Q2 2022.